A Preview Of Medifast's Earnings
Portfolio Pulse from Benzinga Insights
Medifast (NYSE:MED) is scheduled to release its quarterly earnings report on February 20, 2024, with an estimated EPS of $0.96. Despite past earnings beats, Medifast's stock has experienced declines following earnings announcements. Shares are currently trading at $51.46, marking a 52.59% decrease over the last year. Investors are looking for positive guidance for the next quarter.
February 19, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Medifast is expected to report an EPS of $0.96 for the upcoming quarter. Historical data shows stock price declines following earnings beats. Currently trading at $51.46, down 52.59% over the last year.
Given Medifast's history of stock price declines following earnings beats and the significant year-to-date decrease, the upcoming earnings report could potentially lead to further short-term price declines, especially if the earnings beat expectations but fail to provide strong future guidance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100